LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

27.72 -0.43

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

27.35

Max

27.88

Põhinäitajad
By Trading Economics
Sissetulek	-28M 22M
Müük	4.3M 244M
P/E Sektori keskmine	10.28 57.833
Aktsiakasum	1.08
Kasumimarginaal	9.224
Töötajad	293
EBITDA	-22M 52M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+48.11% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	64M 1.6B
Eelmine avamishind	28.15
Eelmine sulgemishind	27.72

Uudiste sentiment

By Acuity

75%

25%

321 / 350 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. märts 2026, 17:19 UTC

Uudisväärsed sündmused

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20. märts 2026, 16:56 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20. märts 2026, 16:56 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20. märts 2026, 16:45 UTC

Uudisväärsed sündmused

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20. märts 2026, 16:22 UTC

Uudisväärsed sündmused

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

20. märts 2026, 20:50 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

20. märts 2026, 20:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

20. märts 2026, 19:55 UTC

Market Talk

Uudisväärsed sündmused

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20. märts 2026, 19:28 UTC

Market Talk

Uudisväärsed sündmused

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20. märts 2026, 19:28 UTC

Omandamised, ülevõtmised, äriostud

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20. märts 2026, 18:39 UTC

Market Talk

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20. märts 2026, 18:31 UTC

Omandamised, ülevõtmised, äriostud

Honeywell Announces Pricing of Debt Tender Offers >HON

20. märts 2026, 18:19 UTC

Omandamised, ülevõtmised, äriostud

Why Mayo and Soap No Longer Mix for Unilever -- Update

20. märts 2026, 18:15 UTC

Market Talk

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20. märts 2026, 17:57 UTC

Market Talk

U.S. Oil Rig Count Inches Up -- Market Talk

20. märts 2026, 17:04 UTC

Uudisväärsed sündmused

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20. märts 2026, 16:20 UTC

Market Talk

Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

20. märts 2026, 16:20 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Health Care Roundup: Market Talk

20. märts 2026, 15:40 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20. märts 2026, 15:30 UTC

Tulu

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20. märts 2026, 15:26 UTC

Market Talk

Tulu

Uudisväärsed sündmused

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20. märts 2026, 15:26 UTC

Omandamised, ülevõtmised, äriostud

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20. märts 2026, 15:25 UTC

Market Talk

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20. märts 2026, 15:19 UTC

Market Talk

Uudisväärsed sündmused

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20. märts 2026, 14:58 UTC

Uudisväärsed sündmused

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20. märts 2026, 14:55 UTC

Market Talk

Uudisväärsed sündmused

Gold Lower as Speculative Pullback Extends -- Market Talk

20. märts 2026, 14:54 UTC

Omandamised, ülevõtmised, äriostud

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20. märts 2026, 14:53 UTC

Omandamised, ülevõtmised, äriostud

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

20. märts 2026, 14:46 UTC

Market Talk

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

20. märts 2026, 14:45 UTC

Market Talk

Uudisväärsed sündmused

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

48.11% tõus

12 kuu keskmine prognoos

Keskmine 41.25 USD 48.11%

Kõrge 62 USD

Madal 25 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

Osta

Hoia

Müü

Põhineb 8 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

321 / 350 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.